3-iodobenzylguanidine has been researched along with Hematologic Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kraal, KC; Tytgat, GA; van Dalen, EC; Van Eck-Smit, BL | 1 |
| Siegel, JA; Sparks, RB; Stabin, MG | 1 |
| Brophy, P; Cheng, SC; Goldsby, R; Hawkins, RA; Huberty, J; Kersun, LS; Maris, JM; Matthay, KK; Messina, J; Quach, A; Veatch, J; Yanik, G | 1 |
| Jones, L; Nwosu, AC; Poston, GJ; Pritchard, DM; Vinjamuri, S; Vora, J | 1 |
| Lasorella, A; Mancini, A; Mastrangelo, R; Mastrangelo, S; Riccardi, R; Rufini, V; Tornesello, A; Troncone, L | 1 |
| Diociaiuti, L; Mastrangelo, S; Riccardi, R; Rufini, V; Tornesello, A; Troncone, L | 1 |
| Glidden, DV; Hasegawa, B; Hawkins, RA; Huberty, J; Matthay, KK; Panina, C; Price, D; Tang, HR; Veatch, J | 1 |
| Arrighini, A; Bertolazzi, L; Bestagno, M; Claudiani, F; De Bernardi, B; Garaventa, A; Guerra, P; Lanino, E; Villavecchia, GP | 1 |
1 review(s) available for 3-iodobenzylguanidine and Hematologic Diseases
| Article | Year |
|---|---|
Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Agents; Bone Marrow; Child; Child, Preschool; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infant; Neuroblastoma; Observational Studies as Topic; Radiopharmaceuticals; Thyroid Diseases; Topotecan | 2017 |
2 trial(s) available for 3-iodobenzylguanidine and Hematologic Diseases
| Article | Year |
|---|---|
Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Cohort Studies; Disease-Free Survival; Follow-Up Studies; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infant; Iodine Radioisotopes; Kaplan-Meier Estimate; Logistic Models; Lymph Node Excision; Neoplasm Staging; Neuroblastoma; Radiation Injuries; Radiopharmaceuticals; Time Factors; Treatment Failure; Treatment Outcome; United States | 2007 |
Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Algorithms; Antineoplastic Agents; Blood Cell Count; Bone Marrow; Brain Neoplasms; Child; Child, Preschool; Female; Hematologic Diseases; Humans; Infant; Male; Neuroblastoma; Radiometry; Radiopharmaceuticals; Whole-Body Counting | 2001 |
5 other study(ies) available for 3-iodobenzylguanidine and Hematologic Diseases
| Article | Year |
|---|---|
Total-body and red marrow dose estimates.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Algorithms; Antineoplastic Agents; Blood Cell Count; Bone Marrow; Brain Neoplasms; Child; Child, Preschool; Female; Hematologic Diseases; Humans; Infant; Male; Neuroblastoma; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage | 2003 |
Assessment of the efficacy and toxicity of (131)I-metaiodobenzylguanidine therapy for metastatic neuroendocrine tumours.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Female; Hematologic Diseases; Humans; Iodine Radioisotopes; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Radiopharmaceuticals; Survival Analysis | 2008 |
A new approach in the treatment of stage IV neuroblastoma using a combination of [131I]meta-iodobenzylguanidine (MIBG) and cisplatin.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Combined Modality Therapy; Hematologic Diseases; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Pilot Projects | 1995 |
Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child, Preschool; Cisplatin; Combined Modality Therapy; Disease Progression; Hematologic Diseases; Hemorrhage; Humans; Infant; Infections; Iodine Radioisotopes; Iodobenzenes; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Prognosis; Radiation-Sensitizing Agents; Radiopharmaceuticals; Remission Induction | 1995 |
Treatment of advanced neuroblastoma with I-131 meta-iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Female; Hematologic Diseases; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Radiotherapy Dosage; Recurrence | 1991 |